Niagen Bioscience, Inc. NAGE 深 沪
已收盘 04-02 16:00:00 美东时间
4.38
-0.140
-3.10%
华盛通- 最 高4.45
- 今 开4.43
- 成交量 75.29万股
- 最 低 4.315
- 昨 收 4.52
- 总市值 3.51亿
- 52周最高 14.69
- 市盈率 静 21.53
- 换手率 0.94%
- 52周最低 4.16
- 委 比 8.17%
- 总股本 8008.05万
- 历史最高 23.66
- 量 比 0.84
- 振 幅 2.99%
- 历史最低 1.15
- 每 手 1
- 风险率 2.52%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Niagen Bioscience Announces OneSpaWorld As Niagen Plus Provider
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced OneSpaWorld (NASDAQ:OSW) as the newest Niagen
03-31 20:39
Niagen Bioscience Increases Buyback Plan From $10M To $20M
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Board of Directors has authorized an
03-19 20:35
Niagen Bioscience Announces External Research Milestone, Surpassing 300 Material Transfer Agreements In NAD+ Research
Niagen Bioscience estimates the program has generated more than $200 million in third-party research value or funding, underscoring the substantial outside investment researchers and institutions have made in studying
03-17 20:40
Niagen Bioscience shares are trading higher after the company reported better-than-expected Q4 financial results. Also, the company issued warm FY26 sales growth guidance.
Niagen Bioscience shares are trading higher after the company reported better-t...
03-05 21:31
Niagen Bioscience Rallies 18% After Hours: Here's Why
Niagen Bioscience Inc. surged in after-hours trading after reporting record 2025 results, while maintaining a cautious outlook for 2026.
03-05 16:56
Niagen Bioscience Q4 Earnings Assessment
The earnings results for Niagen Bioscience (NASDAQ:NAGE) for Q4 were made publi...
03-05 05:44
Niagen Bioscience Q4 EPS $0.05 Beats $0.02 Estimate, Sales $33.839M Beat $31.705M Estimate
Niagen Bioscience (NASDAQ:NAGE) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.02 by 127.27 percent. This is a 44.44 percent decrease over earnings of $0.09 per share from
03-05 05:03
Earnings Scheduled For March 4, 2026
Companies Reporting Before The Bell • Dingdong (Cayman) (NYSE:DDL) is estimated...
03-04 19:11
Niagen Bioscience Announces Sale Of ChromaDex Reference Standards Business To LGC In All-Cash Transaction
Divestiture streamlines operations and advances the Company's strategy to fully exit non-core activitiesNiagen Bioscience, Inc. (NASDAQ:NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus
02-26 20:12
Niagen Bioscience Acquires NR Patent Portfolio, Securing Sole Ownership Of Core NAD+ Intellectual Property; No Financial Terms Disclosed
This acquisition establishes Niagen Bioscience as the sole owner of the most comprehensive and defensible intellectual property portfolio in the NAD+ industryNiagen Bioscience, Inc. (NASDAQ:NAGE), the global authority on
2025-12-22 21:34
